VTAK Stock Analysis: Buy, Sell, or Hold?
VTAK - Catheter Precision, Inc.
$0.71
-0.05 (-6.98%)
▼
5d:
-26.9%
30d:
-30.13%
90d:
-24.97%
WAIT
LOW Confidence
Analysis Updated: Jul 7, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When VTAK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called VTAK this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: VTAK is down 26.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: VTAK is down 26.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: VTAK is currently trading at $0.71, which is considered oversold relative to its 30-day fair value range of $0.84 to $1.09.
Technical Outlook: Technically, VTAK is in a strong downtrend. The price is currently testing key support at $0.81. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.00 (+180.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VTAK is in a strong downtrend. The price is currently testing key support at $0.81. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.00 (+180.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.84 -
$1.09
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.0%)
- BULLISH: Trading 180.6% below Wall St target ($2.00)
- WARNING: Recommendation downgraded due to -26.9% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.84 -
$1.09
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.81
Resistance Level
$1.09
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.23
Wall Street Target
$2.00
(+180.6%)
Revenue Growth (YoY)
202.1%
Share & Embed Analysis
Last updated: July 07, 2026 7:08 PM ET
Data refreshes hourly during market hours. Next update: 8:08 PM
Data refreshes hourly during market hours. Next update: 8:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VTAK showing a specific setup today?
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$75 | 65 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 64 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 64 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 67 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$240 | 60 HOLD |
